Verona Pharma plc Gains 44.32%
Tue, Aug 09, 2022 at 07:16 PM
Verona Pharma plc (VRNA:NASDAQ) rocketted at $10.03, representing a gain of 44.3%. On Tue, Aug 09, 2022, VRNA:NASDAQ hit a New 2-Week High of $10.03. The stock appeared on our News Catalysts scanner on Tue, Aug 09, 2022 at 06:54 PM in the 'PUBLIC OFFERING' category. From Tue, Jul 26, 2022, the stock recorded 70.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Aug 09, 2022 at $14.69 with a volume of 37M+.
About Verona Pharma plc (VRNA:NASDAQ)
Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators.
Top 10 Gainers:
- AeroClean Technologies Inc. (AERC:NASDAQ), 60.13%
- BBQ Holdings, Inc. (BBQ:NASDAQ), 46.59%
- Verona Pharma plc (VRNA:NASDAQ), 44.32%
- FaZe Holdings Inc. (FAZE:NASDAQ), 42.41%
- Mersana Therapeutics, Inc. (MRSN:NASDAQ), 33.33%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 32.14%
- Akanda Corp. (AKAN:NASDAQ), 30.21%
- Atara Biotherapeutics, Inc. (ATRA:NASDAQ), 29.2%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 25.85%
- D-Wave Quantum Inc. (QBTS:NYSE), 24%